on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights is committed to eliminating Antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
AI & Data Tech to Corner AMR 2020: postponed!
Postponed to 2021!
One day International Matchmaking Symposium to advance the use of Artificial Intelligence, Blockchain and Internet of Things to combat AMR
11/06/2020 - 11/06/2020 | Amsterdam
3rd Global Congress on Antibiotics, Antimicrobials & Resistance
Antibiotics Congress welcomes all the Researchers, Eminent professors, Academicians, Industry professionals, Young researchers and Exhibitors from all over the world.
15/06/2020 - 16/06/2020 | Rome (Italy)
Latest news on AMR
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities
To encourage development of new treatments, some commentators have suggested regulators exercise increased flexibility on the clinical evidence required for approval.